Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban

The review presents literature data on the key role of platelet aggregation (PA) for intracoronary thrombogenesis in various acute coronary syndromes (ACS) and percutaneous coronary interventions (PCI). Clinical pharmacology of main antiplatelet medication (APM) classes is discussed, with emphasis o...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: T. A. Batyraliev, D. V. Preobrazhensky, D. V. Fetzer, B. A. Sidorenko, S. A. Pataraya
Médium: Artigo
Jazyk:Russo
Vydáno: «SILICEA-POLIGRAF» LLC 2008-12-01
Edice:Кардиоваскулярная терапия и профилактика
Témata:
acute coronary syndrome
percutaneous coronary intervention
platelet iib/iiia receptor inhibitors
tirofiban
abciximab
eptifibatide
On-line přístup:https://cardiovascular.elpub.ru/jour/article/view/1638
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky